Hybrid Chatbot for Cancer

This trial tests a new chatbot tool designed to help cancer patients and their caregivers, particularly those in rural areas, manage financial aspects of cancer care such as insurance and travel costs. Participants will be divided into two groups to use either a hybrid chatbot (combining rule-based and AI-enabled features) or an AI-enabled chatbot, to determine which offers better support. The trial seeks cancer patients or their financially responsible caregivers who reside in rural parts of Utah, Idaho, Wyoming, Montana, or Nevada and can read and write in English. As an unphased trial, this study provides a unique opportunity to contribute to innovative solutions that could alleviate financial burdens for rural cancer patients.

The trial information does not specify whether you need to stop taking your current medications. It seems focused on using a chatbot for financial support, so it's unlikely to require changes to your medication.

Research has shown that AI chatbots are generally safe for use in healthcare. These tools offer emotional support and answer questions, benefiting cancer patients and their caregivers. Studies have found that chatbots can improve healthcare outcomes and maintain patient engagement without major safety issues. No reports have indicated problems caused by using AI chatbots like those in this trial.

Researchers are excited about the Hybrid Chatbot for cancer care because it blends artificial intelligence with human oversight, offering personalized support that adapts to patients' needs. Unlike traditional face-to-face counseling or static information websites, this chatbot can provide round-the-clock assistance and tailored responses. The Rule-Based Chatbot, on the other hand, follows predetermined scripts to guide users, making it a reliable and consistent source of information. Both chatbots aim to enhance patient engagement and support, potentially improving the cancer care experience by making it more accessible and user-friendly.

Research has shown that AI-powered chatbots can help cancer patients by offering emotional support and answering questions about their care. In this trial, participants will use either a hybrid chatbot or a rule-based chatbot. The hybrid chatbot, which combines artificial intelligence with set rules, aims to provide more personalized and accurate information. AI chatbots have assisted patients in understanding survivorship issues and connecting them to helpful resources. The hybrid chatbot specifically supports cancer patients, especially those in rural areas, by providing clear information about insurance and travel costs. Although data on this particular hybrid chatbot is limited, AI chatbots in general show promise in improving the patient experience in cancer care.¹²³⁵⁶